Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China：a Prospective, Multicenter, Observational Research

NCT03116854 is registered in ClinicalTrials.gov with Henan Institute of Cardiovascular Epidemiology as lead sponsor.

NCT NCT03116854
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03116854 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Use and Prognosis of Beta Blocker in Patients With Acute Coronary Syndrome in the Central China：a Prospective, Multicenter, Observational Research
Lead sponsor
Henan Institute of Cardiovascular Epidemiology
Phase
Observational
Overall status
Completed
Start date
March 1, 2017
Completion date
April 26, 2020
Enrollment
3,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome